Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes-Reference-Cited by-同舟云学术

Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes

Published:2021-11 Issue: Volume: Page:
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Sjödahl Gottfrid,Abrahamsson Johan,Holmsten Karin,Bernardo Carina,Chebil Gunilla,Eriksson Pontus,Johansson Iva,Kollberg Petter,Lindh Claes,Lövgren Kristina,Marzouka Nour-al-Dain,Olsson Hans,Höglund Mattias,Ullén Anders,Liedberg Fredrik

Funder

Swedish Cancer Society

Publisher

Elsevier BV

Subject

Urology

Reference37 articles.

1. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines;Witjes;Eur Urol,2021

2. The utilization status of neoadjuvant chemotherapy in muscle-invasive bladder cancer: a systematic review and meta-analysis;Liu;Minerva Urol Nefrol,2021

3. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration;Vale;Eur Urol,2005

4. Can biomarkers guide the use of neoadjuvant chemotherapy in T2 bladder cancer?;Grossman;Eur Urol Oncol,2019

5. A molecular taxonomy for urothelial carcinoma;Sjödahl;Clin Cancer Res,2012

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid–liquid phase separation-related genes associated with prognosis, tumor microenvironment characteristics, and tumor cell features in bladder cancer;Clinical and Translational Oncology;2024-09-13

2. Protein-Based Predictive Biomarkers to Personalize Neoadjuvant Therapy for Bladder Cancer—A Systematic Review of the Current Status;International Journal of Molecular Sciences;2024-09-13

3. Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer;BJUI Compass;2024-09-11

4. Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges;European Urology Focus;2024-09

5. Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer;Cancer Medicine;2024-08